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Murine coronavirus mouse hepatitis virus (MHV) is a member of
the Coronaviridae. It is an enveloped, positive-strand RNA virus. The
viral envelope contains three or four structural proteins, depending
on viral strains (Lai and Cavanagh, 1997). The spike (S) protein is a
glycoprotein with a molecular weight of approximately 180 kilo
Dalton (kDa). For some MHV strains such as JHM and A59, the S
protein can be cleaved by a furin-like proteinase into two subunits:
the amino terminal S1 and the carboxyl-terminal S2. The S1 subunit is
thought to form the globular head of the spike and is responsible for
the initial attachment of the virus to the receptor on cell surface. The
S2 subunit, which forms the stalk portion of the spike and which
anchors the S protein to the viral envelope, facilitates the fusion
between viral envelope and cell membrane and cell–cell fusion
(Chambers et al., 1990; de Groot et al., 1987; de Haan et al., 2004;
Gallagher et al., 1991; Kubo et al., 1994; Luytjes et al., 1987; Nash and
Buchmeier, 1997; Stauber et al., 1993; Suzuki and Taguchi, 1996; Zhu
et al., 2009). It is therefore an important determinant for viral
infectivity, pathogenicity and virulence (Boyle et al., 1987; Collins
et al., 1982; Phillips et al., 1999). The small envelope (E) protein andthe membrane (M) protein play a key role in virus assembly
(Vennema et al., 1996; Yu et al., 1994). The nucleocapsid (N) protein
is a phosphoprotein of approximately 50 kDa and is associated with
the RNA genome to form the nucleocapsid inside the envelope (Lai
and Cavanagh, 1997; Stohlman and Lai, 1979). Upon entry into host
cells, the viral genomic RNA serves as an mRNA for translation of the
viral polymerase polyprotein from the 5′ most overlapping open
reading frames 1a and 1b (Lai and Cavanagh, 1997). The polyprotein is
then processed into 16 nonstructural proteins (nsp's), which possibly
along with host factors form replication and transcription complexes
that generate a nested-set of subgenomic mRNAs (Lai and Cavanagh,
1997; Snijder et al., 2003). Each subgenomicmRNA is translated into a
structural or nonstructural protein. The structural proteins are
assembled into virions in cytoplasmic vesicles (Vennema et al.,
1996), which are then released (exocytosed) from the infected cell.
MHV can infect rodents, causing hepatitis, enteritis, and central
nervous system (CNS) diseases. In the CNS, acute encephalitis usually
occurs during the ﬁrst week of infection, and acute demyelination can
be detected histologically as early as 6 days post infection (p.i.). By the
end of the secondweek, if themice survive virus infection, most of the
viruses are cleared from the CNS, and demyelination develops.
Although infectious virus can no longer be isolated from the CNS
during the chronic phase (≈3 weeks p.i.), viral RNAs are continuously
detectable by Northern blot or reverse transcription-polymerase
chain reaction (RT-PCR). Demyelination continues to peak at around
30 days p.i., and then slowly decreases until over a year p.i.,
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Sarma et al., 2000; Fleming et al., 1993a; Knobler et al., 1981, 1982;
Lavi et al., 1984). Although the mechanisms of MHV-caused CNS
demyelination are not known, it is believed that the host immune
response plays an important role in the demyelination process
(Dandeker and Perlman, 2002; Fleming et al., 1993b; Lai and
Cavanagh, 1997; Lane et al., 2000; Matthews et al., 2002; Sorensen
et al., 1987; Wang et al., 1990; Wu and Perlman, 1999, Wu et al.,
2000). It has been shown that the development of demyelination in
mice is associated with viral RNA persistence (Das Sarma et al., 2000;
Knobler et al., 1982), but the mechanism of CNS persistence remains
largely unknown.
Previously, a number of laboratories have attempted to establish an
in vitro cell culture system for MHV persistence (Chen and Baric, 1996;
Lavi et al., 1987; Sawicki et al., 1995; Schickli et al., 1997). While these
studies have led to the establishment of MHV persistence in ﬁbroblast
17Cl-1 cells, astrocytoma DBT cells and primary oligodendrocytes,
infectious viruses continued to be produced, albeit at an extremely low
level (Chen and Baric, 1996; Lavi et al., 1987; Sawicki et al., 1995;
Schickli et al., 1997). Thus, such persistence does not resemble the
phenomenon observed in mouse CNS. Although we have previously
reported the establishment of a persistent, non-productive infection in a
rat progenitor oligodendrocyte cell line (Liu et al., 2003; Liu and Zhang,
2005), the cells that harbor persistent viruses have not been conﬁrmed,
largely due to difﬁculty in separating infected cells fromuninfected cells
in a mixed culture. In an effort to establish a robust in vitro system that
can faithfully recapitulate the in vivo phenomenon, in the current study
wemade several modiﬁcations in our experimental approach. We used
a recombinant MHV that expresses a green ﬂuorescence protein (GFP)
such that infected cells can be easily identiﬁed and separated from non-
infected cells. Using this approach, we were able to identify a new type
of mouse oligodendroglial cell line (N20.1) that was persistently
infected with MHV. Consistent with the results in rat progenitor
oligodendrocytes (Liu and Zhang, 2005), viral RNA persisted for over 14
passages without the production of infectious virus. Signiﬁcantly and
unexpectedly, we discovered that persistently infected oligodendro-
cytes continued to produce viral particles but that these particles were
deﬁcient in incorporation of spike proteins on the virion surface, thus
providing a mechanism for the lack of viral infectivity. To our
knowledge, this is theﬁrst report in virology describing non-productive,
persistent infection that continuously produces virus particles without
infectivity due to a lack of spike protein incorporation.
Results
Establishment of persistent MHV infection in mouse oligodendroglial
cells
We previously reported the establishment of a persistent MHV
infection in a rat progenitor oligodendrocytic cell lineCG-4 cells (Liu and
Zhang, 2005). However, itwasnot clear in that studywhether all cells or
only a fraction of the cell population were initially infected with MHV.
This question is important because the mechanism of persistence could
be different under these conditions. To unequivocally address this
question and to identify additional cell lines for such studies, we used
the recombinant MHV-A59/GFP, which expresses the GFP, and two
additional mouse oligodendrocytic cell lines N20.1 (Verity et al., 1993)
and Oligo-neu (Jung et al., 1995). The rationale for usingMHV-A59/GFP
was to quantitatively assess the susceptibility of the cell population to
virus infection and to track the extent of viral persistence following
continuous passage of the cells. Thus, CG-4, N20.1 and Oligo-neu cells
were infected withMHV-A59/GFP at anm.o.i. of 10, and were observed
for GFP expression. We found that less than 0.1% of the CG-4 cells
expressed strong GFP at 24 and 48 h p.i. (data not shown) while
approximately 25% of N20.1 cells (Fig. 1B, a–b) and b20% of Oligo-neu
cells exhibited strong ﬂuorescence for the same time period (data notshown). Because of the highest cell number of GFP expression and
relative ease in culture, N20.1 cells were used in all subsequent
experiments described in this report.
Infected N20.1 cells were subjected to ﬂow cytometric sorting (Fig. 1).
Strong GFP-expressing cells were separated from non-GFP-expressing
cells andwere re-seeded intodishes (Fig. 1B, c–d),whichweredesignated
as VP1 (for passage 1 of virus-infected cells). To our surprise and
disappointment, most of the green ﬂuorescence disappeared by days 7 to
10 after seeding (Fig. 1B, e–f). Nevertheless,we continued to replenish the
medium every other day and allowed the cells to grow tomonolayers for
additional 15 to 20 days. The monolayer cells were further passaged
approximately every 8 days and were designated as VP2, VP3, and so
forth.
To determine whether the infection was aborted after disappear-
ance of the green ﬂuorescence at the end of VP1, monolayer cells
(approximately by 30 days after seeding of GFP-positive cells) were
collected and the presence of viral genomic RNAs in the cells was
determined by RT-PCR using 5 pairs of primers that represent 5
regions throughout the viral genome (Fig. 2A). Indeed, viral genomic
RNAs were detected with all 5 pairs of primers (Fig. 2B), conﬁrming
the presence of the viral genome. We then isolated intracellular RNAs
from various passages of the infected cells (VP1 to VP14) and used
RNAs from acutely infected (VP0) and mock-infected N20.1 cells as a
positive and negative control, respectively, for RT-PCR with the
primer pair 5′N and 3′N. Results showed that viral genomic RNAs
were present in all passages tested (Fig. 2C). Thus, real-time qRT-PCR
(using primer pair 5′qPCR and 3′qPCR) was used to further quantify
the viral genomic RNAs in these passages. It was found that in general
the amount of viral genome decreased drastically from VP0 to VP4,
but relatively slowly thereafter (Fig. 2D). These data demonstrate that
viral genomic RNAs established persistence in N20.1 cells for a period
of time long after the disappearance of GFP expression.
Loss of GFP expression is associated with aberrant transcription of
subgenomic mRNA4 coding for GFP in persistently infected oligodendrocytes
Since viral genomic RNAs persisted (Fig. 2), we assumed that viral
genomic replication must have taken place continuously, and so must
have been the expression of the viral polymerase polyprotein, the ORF
1a/1b product. However, the eventual disappearance of GFP-positivity
led us to further examine potential defects in viral gene expression in
persistently infected N20.1 cells since the GFP ORF is under the control
of the consensus intergenic sequence for subgenomic mRNA 4
(Fig. 3A) (Das Sarma et al., 2002). Thus, both the genomic regions
encompassing the GFP coding sequence and the subgenomic mRNA4
at VP4 were speciﬁcally ampliﬁed by RT-PCR using the pair of primers
5′IG4–3′G5a and 5′Leader–3′G5a, respectively, and the PCR products
were sequenced directly or following shotgun cloning. Interestingly,
we found that the entire GFP ORFwas intact within the persistent viral
genome (data not shown) but that there were multiple species of
subgenomic mRNA4 varying in size (Fig. 3B). These mRNAs contained
a leader RNA fused at multiple sites downstream of the AUG
translation initiation codon, thus effectively abolishing the expression
of the GFP gene, a phenomenon reminiscent of the aberrant
transcription described previously for MHV (Fischer et al., 1997;
Zhang and Lai, 1994).
Expression of viral genes in persistently infected oligodendrocytes
Theﬁnding of aberrant transcription of subgenomicmRNA4 (GFP) led
us to further examine whether the other viral subgenomic mRNAs were
also transcribed aberrantly. Thus, the expression of viral subgenomic
mRNAs coding for structural proteins and their protein products was
assessed in various passages of the persistently infected N20.1 cells. As an
example shown in Fig. 4, mRNA7 (for N gene) and mRNA3 (for S gene)
weredetected in various passages of thepersistently infected cells but not
Fig. 1. Establishment of persistent MHV infection in oligodendroglial N20.1 cells. (A) Schematic diagram showing the procedure for establishing persistent infection. N20.1 cells were
infected with MHV-A59/GFP at the m.o.i. of 10. Virus-infected cells at passage 0 (VP0) were subjected to FACS sorting. GFP-positive cells were re-seeded as VP1 and were allowed to
grow tomonolayer. VP1 cells were subsequently passaged, which are designated VP2, VP3, and so forth (VPn). (B) Monitoring GFP expression in virus-infected N20.1 cells. a, c, and e,
showing GFP expression at various steps during the procedure; b, d, and f, showing the number of GFP-positive cells relative to the GFP-negative cells within the same ﬁeld. The
photographs were taken when both visible and ﬂuorescent lights were turned on. a–b, GFP expression in VP0 cells at 48 h p.i. In general, approximately 25% of the cells were GFP-
positive at 48 h p.i. c–d, GFP-positive cells following FACS sorting (VP1 cells), showing that almost all cells were GFP-positive. e–f, GFP-positive cells disappeared at subsequent
passages of infected cells.
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(5′Leader–3′S1 and 5′Leader–3′N) that speciﬁcally detect the respective
mRNA species (Fig. 4A). Similarly, viral N and S proteins were detected in
these persistently infected cells by Western blot analysis and their
expressionappeared todeclineover continuouspassageswhencompared
to theβ-actin control (Figs. 4DandE).mRNAs for other structural proteins
(MandE)werealsodetected (datanot shown). These results conﬁrmthat
virus-speciﬁc genes, especially structural genes, were expressed in
persistently infected N20.1 cells.
Absence of infectious virus following establishment of genome persistence
To determine whether and to what extent infectious virus was
produced during persistence, both culture medium and cell lysate
were used for determining the presence of infectious virus in various
passages by plaque assay. Indeed, virus titers were decreased from
approximately 105 PFU/ml during acute infection (VP0) to about
102 PFU/ml at VP1. No infectious virus was detected beyond passage 2
(VP2) (Fig. 5A and further data not shown). To further determine the
time point at which infectious virus was no longer recoverable,
medium and cell lysate were collected at various days after seeding of
the ﬂuorescence-positive cells at VP1. The results showed that virus
titer decreased gradually and reached to an undetectable level (the
detection limit of the plaque assay was approximately 5 PFU/ml) by
day 15 (Fig. 5B). These results, combined with the data shown in
Figs. 1–4, reafﬁrm that MHV established persistence of viral genome
in oligodendrocytes without the production of infectious viruses or
with extremely low level of infectious virus (below the detectionlimit). This phenomenon resembles viral RNA persistence in the CNS
of MHV-infected mice.
Biophysical and biochemical characterization of virions produced from
persistently infected oligodendrocytes
Since no infectivity was detected in the medium and lysate of
persistently infected N20.1 cells, we wondered whether viral particles
had ever been made. Culture medium was collected from persistently
infected N20.1 cells between passages 6 and 10. Virions, if any, were
concentrated through 30% sucrose cushion and were further puriﬁed
via 20–70% sucrose gradient by ultracentrifugation. The gradient was
then fractionated and the buoyant density of each fraction was
determined. Presence of viral N protein was determined by Western
blot using an N-speciﬁc mAb. As shown in Fig. 6A, N protein was
detected in the fractions 5 to 10, which correspond to the buoyant
density between 1.14 and 1.20 g/ml. The standard buoyant density in
sucrose for MHV-A59 is 1.18–1.19 g/ml (Liebermann, 1982), which
corresponds to fraction 8 in Fig. 6A. Since the majority of N protein
was present in fractions 5–6, the data indicate that virus particles
were likely produced but that they were slightly lighter than the
infectious virus, suggesting some kind of defects with the virus
particles. One possibility for a lower buoyant density is the lack of viral
genomic RNA, i.e. virus-like particles. However, since the N protein is
associated with the genome, the detection of N protein in the viral
fractions argues against this possibility, although N protein can also
interact with M protein during assembly (Narayanan et al., 2000).
Nevertheless, to experimentally demonstrate this possibility, fractions
Fig. 2. Persistence of viral genomic RNAs in N20.1 cells. (A) Schematic diagram showing
viral genome organization with highlight of genes 1a/1b, S and N, and the relative
locations (arrows) and names of the primer pairs used in the RT-PCR detection. (B)
Detection of viral RNA genome in persistently infected N20.1 cells at passage 4 (VP4).
Five RT-PCR products (1a, 1b, S1, S2, and N) represent the 5 regions throughout the viral
genome as shown in (A). Unmarked lanes on both sides are molecular weight marker in
base pair (bp). (C) Detection of viral genomic RNA at various passages (VP0–VP14) of
the persistently infected N20.1 cells. The RT-PCR product corresponds to the region
within the N gene as shown in (A). M, mock-infected cells as a negative control.
Molecular weight markers are shown on both sides in bp. (D) Real-time quantitative
RT-PCR detection of viral genomic RNA at various passages (VP0–VP12). The number
represents the relative amount of viral genomic RNA (fold) above the background.
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Fig. 3. Loss of GFP expression is associated with aberrant transcription of subgenomic
mRNA4 coding for GFP in persistently infected N20.1 cells. (A) Schematic diagram
showing viral genome (gRNA) organization and transcription of subgenomic (sg)
mRNA4, the relative locations (arrows) and names of the primer pairs used in the RT-
PCR. (B) Schematic diagram showing various species of sgmRNA4 identiﬁed by
sequencing. The mRNAs have a leader RNA fused with the body sequence at various
locations within the GFP open reading frame. A total of 10 clones of the RT-PCR products
were sequenced. The number of clones representing each mRNA species is shown on
the right.
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primers speciﬁc to viral genome within the N gene-coding region.
Indeed, speciﬁc viral genomic RNAs were detected in the puriﬁed
fractions from persistently infected N20.1 cells (Fig. 6B, lane VP) and
in virus samples derived from acutely infected 17Cl-1 cells that served
as a positive control (Fig. 6B, lane V). Viral RNAs were not detected in
samples derived from mock-infected N20.1 or 17Cl-1 cells (Fig. 6B).
These results conﬁrm that viral genomes were present in the fractions
that represent viral particles.
We next determined the viral structural proteins in the puriﬁed
“virions”. We used antibodies to viral S, N, and E proteins in Western
blot. As shown in Fig. 6C, all these viral structural proteins were
detected. However, in comparison with the viruses propagated in
17Cl-1 cells, the amount of S protein was very low relative to the
amount of N protein. We also noticed that the amount of S protein
expressed in the persistently infected cells was extremely low at late
passages (Fig. 4E). It is worth noting that due to the absence of
infectivity for virion isolated from persistent cells, it was not possible
to precisely quantify the virion protein by loading an equivalent PFU.Thus, the ratio of envelope proteins (S and E) to N protein was used as
a measure for describing the relative amount of envelope protein per
physical particle. In addition, the species of the virion S protein from
persistently infected N20.1 cells appeared to be different from that
from acutely infected 17Cl-1 cells. Similar phenomenon was also
observed between the S proteins in acutely and persistently infected
cells (compare with Fig. 4E). However, it remains to be seen whether
this is due to differential glycosylation or other post-translational
modiﬁcations. The E protein from persistently infected N20.1 cells
appeared less abundant compared to that from 17Cl-1 cells (Fig. 6C,
lower panels). We also detected the M protein from persistently
infected N20.1 cells and 17Cl-1 cells; however, due to high
background, we were unable to compare its relative amount in
different cell types (data not shown).Morphological features of the virions isolated from persistently infected
oligodendrocytes
The detection of viral structural proteins and RNA genome in the
puriﬁed sucrose gradient fractions in above experiments indicates
that virions were likely assembled. However, the absence of
infectivity prompted us to examine the morphology of the viral
particles. Thus, puriﬁed virus preparations were subjected to
negative-staining followed by electron microscopic examination. In
general, diverse morphology of the virions had been observed in each
grid for the same sample (Fig. 7). The shape and size of the virions
isolated from acutely or persistently infected N20.1 cells and from
17Cl-1 cells were indistinguishable. Interestingly, however, little to no
spike was found on the virions isolated from persistently infected
N20.1 cells (panels a–b). In contrast, virions isolated from acutely
infected N20.1 or 17Cl-1 cells exhibited the typical “crown”
morphology of the coronavirus, i.e. the spike protein protruding
from the virion surface to form a ring (panels c–e). Thus, it appears
that the only obvious morphological distinction between infectious
and non-infectious virions is the presence or abundance of the spike
protein on virion surface observed under EM examination.
Fig. 4. Expression of viral genes in persistently infected N20.1 cells. (A) Schematic
diagram showing viral genome organization with highlight of genes 1a/1b, S and N, the
subgenomic mRNAs for the S and N genes, and the relative location and name of the
primer pairs used in the RT-PCR. (B and C) Detection of subgenomic mRNAs for N and S
genes, respectively, in acutely and persistently infected N20.1 cells at various passages
(VP0–VP14). M, mock-infected cells as a negative control. Molecular weight marker is
shown on the left in base pair (bp). (D and E) Detection of viral N and S protein,
respectively, in acutely and persistently infected N20.1 cells at various passages (VP0–
VP14) by Western blot analysis. M, mock-infected cells as a negative control. β-Actin
was used as an internal control for protein loading.
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(VP1). The results are expressed as an average PFU per ml of two samples for each time
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envelope proteins during persistence in oligodendrocytes
It has been suggested that incorporation of S protein into virion
envelope requires the interaction between S and M proteins, more
speciﬁcally between the transmembrane and amphipathic domains of
M protein and the carboxyl-terminal domain of the S protein (Fig. 8A)
(de Haan et al., 1999; de Haan and Rottier, 2007). While the E protein
is not absolutely required for replication, lack of E drastically reduces
viral replication and ﬁtness (Kuo and Masters, 2003). Thus, to gain an
insight into potential defects associated with S protein incorporation,
we determined whether any mutations in the carboxyl-terminal
domain of S protein or M and E proteins arisen during persistence
might contribute to the lack of incorporation. We ampliﬁed a
sequence at the 3′-end of S gene that encodes the carboxyl-terminal
domain of the S protein (including the transmembrane domain andcytoplasmic tail) from various passages of persistently infected N20.1
cells (Figs. 8B and C). We also ampliﬁed the entire ORFs of the M and E
gene from acutely (VP0) and persistently infected N20.1 cells at
passages 10 (VP10) and 16 (VP16) (Figs. 8B and C). Direct sequencing
of the RT-PCR products (Fig. 8C) revealed that there was no single
nucleotide mutation at the 3′-end of the S gene andwithin the ORF for
M and E genes (data not shown). These results suggest that deﬁcient
incorporation of S protein in the virions during persistence unlikely
results from lack of interactions among envelope proteins due to
mutations in the interacting domains.
Discussion
The hallmark of MHV persistent infection in the animal CNS is the
persistence of viral genomewithout the detection of infectious viruses
(Bergmann et al., 2006). To recapitulate this in vivo phenomenon it
would be highly desirable to have a robust in vitro cell culture system,
such that the molecular mechanisms of viral persistence can be
carefully examined at the cellular level. In an effort to achieve that
objective, over the past decades we and others have searched a large
number of susceptible cell lines and primary cell cultures for their
potential as hosts for MHV persistence. Although these investigations
have established MHV persistence in many types of cells following
variousmanipulations of culture conditions, persistently infected cells
continue to produce infectious viruses (Chen and Baric, 1996; Lavi
et al., 1987; Sawicki et al., 1995; Schickli et al., 1997). Only the rat
progenitor oligodendrocyte CG-4 cell line has been reported to harbor
MHV genomes without producing infectious viruses (Liu and Zhang,
Fig. 6. Biophysical and biochemical characterization of virus preparations isolated from
persistently infected N20.1 cells. (A) Determination of virus buoyant density. Following
puriﬁcation of the virus preparations, the sucrose gradient was fractionated and the
buoyant density (g/ml) for each fraction was determined and plotted (see Materials and
methods). The presence of virus in each fraction was further determined byWestern blot
analysis using a mAb speciﬁc to viral N protein. The dashed line indicates the standard
buoyant density (1.18–1.19 g/ml) for coronaviruses as a reference. (B) Presence of viral
genomic RNA in thepuriﬁed viral preparations. RNAswere isolated from gradient-puriﬁed
fractions. RT-PCR was performed to detect viral genomic RNAs (VP). Preparations from
mock-infectedN20.1 cells or 17Cl-1 cellswereusedasa negative controlwhilepreparation
from acutely infected 17Cl-1 cells (V) was used as a positive control. Arrow indicates the
unique RT-PCR product representing viral RNA. (C) Presence of viral structural proteins in
the gradient-puriﬁed virus preparations from persistently infected N20.1 cells was
determined by Western blot using antibodies to MHV S, N and E proteins. Virus
preparations from acutely infected 17Cl-1 cells were puriﬁed in parallel and used as a
positive control.
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been infected with MHV (Liu and Zhang, 2005). It is more likely that
only a small population of cells were initially infected with MHV or
were permissive for MHV replication, because less than 1% of the
infected cells exhibited strong ﬂuorescence when stained with an
antibody speciﬁc to MHV N protein (Liu et al., 2003). This suggests
that only a tiny fraction of the cells may persistently harbor the virus.
In the present study, we employed a recombinant MHV that expresses
GFP. This improvement allows us to screen multiple cell lines for their
susceptibility to MHV infection and to identify and isolate infected
cells. Indeed, we found that≈25% of N20.1 cells exhibited strong GFP
expression (Fig. 1). Subsequent FACS sorting and subcultures of the
GFP-positive N20.1 cells led to the establishment of persistent
infection without production of infectious viruses (Figs. 1–4), which
recapitulates the phenomenon observed in mouse CNS. Thus,
establishment of such a faithful system paves the foundation for
future mechanistic studies of MHV persistence in CNS cells.
Ironically, non-productive persistence is established only in 3 cell
lines of oligodendrocytic origin (mouse oligodendrocyte N20.1 and
Oligo-neu (this study) and ratprogenitor oligodendrocyteCG-4 (Liu and
Zhang, 2005)) in spite of different conditions used for establishing these
cell lines. This raises a possibility that this kind of MHV persistence is
cell-type speciﬁc. CG-4 cell is a permanent, undifferentiated type 2
oligodendrocyte/astrocyte progenitor cell that was originally estab-
lished during a primary neural cell culture derived from the brain of
newborn (1–3 days postnatal) Sprague–Dawley rat pups (Louis et al.,1992). It is maintained at the progenitor state under complex culture
conditions containing various growth factors. It can differentiate into
mature oligodendrocyte upon changing culture conditions. N20.1 cell
is a cell line clone derived from mouse primary cultures of oligoden-
drocytes conditionally immortalized by transformation with a temper-
ature-sensitive mutant of the simian virus 40 large-T antigen (Verity
et al., 1993). The Oligo-neu is a murine oligodendroglial precursor cell
line established via transformation of a replication-defective retrovirus
expressing t-neu oncogene linked to the external region of the human
epidermal growth factor receptor (Jung et al., 1995). Although the 3 cell
lines were derived from different animal species and were established
by different methods, they appear to retain the susceptibility to non-
productive persistence by MHV. This is in stark contrast to ﬁbroblast
(17Cl-1) and astrocytoma (DBT) cell lines (Chen and Baric, 1996;
Sawicki et al., 1995), where infectious virus continues to generate.
Another difference between the non-productive persistence in N20.1
cells and the productive persistence in ﬁbroblast and astrocytoma cell
lines is that persistence can be established only in mixed (infected and
uninfected; susceptible and resistant) cultures of 17Cl-1 and DBT (Chen
and Baric, 1996; Sawicki et al., 1995). In such mixed cultures with low
multiplicity of infection, a small number of viruses released froma small
fraction of cell populations can infect neighboring uninfected cells and
thus thepersistence canbemaintained inanepigenetic fashion (Sawicki
et al., 1995). The persistence in N20.1 cells was established following
selection of infected cells. When GFP-expressing 17Cl-1 or DBT cells
were selected by the same FACS sorting following infection with MHV-
A59/GFP, continuous passaging of the GFP-expressing 17Cl-1 and DBT
cellswas not possible, due to extensive cell death for 17Cl-1 asdescribed
by Chen and Makino (2002) or extensive cell fusion for DBT cells.
However, it has been reported that infectious virus continued to
produce in persistently infected primary mouse oligodendrocytes (Lavi
et al., 1987). One possible reason for the observed difference between
primary oligodendrocytes and established oligodendroglial cell lines is
that primary oligodendrocytes cannot be subcultured for many
passages, thus leaving insufﬁcient time for eventual cease of infectious
virus production to take place. Another possibility is that culture
conditions used for primary cells and cell linesmight be different, which
can affect cell proliferation and differentiation,which in turn affect virus
replication and infectious virus production. A third possibility is that
most primary cultures have a certain degree of impurity, i.e.,
contamination with a small number of astrocytes and microglia that
can serve as a reservoir for infectious virus production, albeit at a low
level.
One of our initial purposes to use the GFP-expressing virus was to
continuously monitor progression of the persistent infection. How-
ever, the eventual disappearance of GFP-positivity is unexpected.
Interestingly, while aberrant transcription of subgenomic mRNA for
GFP gene, a phenomenon reminiscent of the aberrant transcription
described previously for MHV (Fischer et al., 1997; Zhang and Lai,
1994), was identiﬁed (Fig. 3), subgenomic mRNAs coding for viral
structural proteins such as S, E, M, and N were transcribed with no
apparent abnormality; further Western blot analyses conﬁrmed the
expression of these viral structural proteins (Figs. 2 and 4 and further
data not shown). Thus, it appears that MHV has the ability to
selectively inactivate the GFP gene expression through aberrant
transcription while keeping viral own genes continuously expressed.
Why and how MHV can discriminate self from non-self during gene
expression remain an interesting subject for future investigation.
It has been known for decades in the coronavirus research ﬁeld
that MHV can establish persistent infection in the mouse CNS without
apparent production of infectious viruses. This kind of so-called non-
productive persistence is unique among animal viruses. The most
intriguing question remained to be answered, however, is what the
major defects in the virus life cycle are associated with the non-
productive persistence. Despite the enormous technical challenges on
studying persistent infection, our comprehensive biophysical,
Fig. 7. Deﬁcient incorporation of spike protein in viral particles isolated from persistently infected N20.1 cells. (a–b) Negative-stain electron micrographs of viral particles isolated
from persistently infected N20.1 cells, showing a lack or deﬁciency of spikes. Panels a1–a3 are higher magniﬁcation images of viral particles shown in (a). The arrows in a3 indicate
possible “spikes”. (c) EM images for virions isolated from acutely infected N20.1 cells, showing the typical crown-like spikes. (d–e) EM images for virions isolated from acutely
infected 17Cl-1 cells, showing the spikes protruding from virion surface. The size bar indicates 100 nm.
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Fig. 8. Analysis of virion envelope genes from persistent N20.1 cells. (A) Membrane topology of MHV-A59 envelope proteins. The rectangular shade highlights the transmembrane
and C-terminal domains of S andM proteins involved in interaction and spike incorporation during virion assembly. (B) Diagram showing S, M and E genes in viral genomic RNA and
the location and name of the primer pairs used in RT-PCR. (C) Agarose gel showing the RT-PCR products of viral S, M, and E genes from various passages of the persistently infected
N20.1 cells (VP). VP0 indicates RNA samples isolated from acute infection at 48 h p.i.; U, uninfected. Molecular weight marker is shown in base pair (bp).
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in the virus life cycle, which may contribute to the lack of viral
infectivity. We found that viral genomic RNAs continuously replicate,
that subgenomic mRNAs are transcribed, and that viral structural
proteins are expressed in persistently infected N20.1 cells. Successful
continuation of these processes likely contributes to the maintenance
of viral persistence. However, we also found that while viral particles
are assembled in the persistently infected cells (Figs. 6 and 7), these
virions are not infectious upon infection of susceptible DBT cells (data
not shown), although continuous blind passage of “infected” DBT cells
has not been carried out. Themost likely reason for a lack of infectivity
of these virions is deﬁciency in incorporation of viral spike protein
into the viral envelope, since spike protein is the key determinant for
coronavirus infectivity. This is evidenced with the EM examination,
which shows that virions isolated from persistently infected cells
scarcely have spikes protruding from virion surface. Although the
spike sometimes can get lost following the puriﬁcation procedures,
the overwhelming presence of spikes in virions isolated from acutely
infected N20.1 or 17Cl-1 cells, which have been subjected to the same
puriﬁcation procedures in parallel experiments, suggests that the
deﬁciency in spike incorporation into persistent viral particles is
not simply caused by technicality; rather it is more likely due to
some kind of defects in virion assembly. However, since virions from
acutely infected N20.1 cells are infectious and have abundant spikes
(Fig. 7, d–e), this ﬁnding suggests that defective incorporation of spike
protein may have occurred following the establishment of persistent
infection.
What caused defective incorporation of spike protein? Since there
are no apparent mutations in virion envelope proteins (Fig. 8)
associated with S incorporation (de Haan et al., 1999; de Haan and
Rottier, 2007), we hypothesize that some cellular factors that are
triggered byMHV infection and persistencemight in turn inhibit spike
protein incorporation into virions. It has been reported that treatment
of cells with type I interferon (IFN) signiﬁcantly inhibited the
glycosylation of vesicular stomatitis virus (VSV) G protein, the
incorporation of G protein into virions and the virus infectivity
(Maheshwari et al., 1980a,b; Jay et al., 1983). It has also been shown
that inhibition of glycosylation of MHV S protein by the drug
tunicamycin led to retention of unglycosylated S protein in theendoplasmic reticulum (ER), prevented S protein from incorporation
into virions and resulted in production of spikeless virions and loss of
viral infectivity (Holmes et al., 1981; Rottier et al., 1981). Similarly,
infection with two temperature-sensitive mutants of MHV-A59
resulted in lack of the mature Golgi form and oligomerization of S,
retention of the S in the ER, and lack of S in puriﬁed virions produced
at the non-permissive temperature (Luytjes et al., 1997). A mutant
isolated from DBT cells persistently infected with MHV-JHM strain
exhibited slightly lower buoyant density and had fewer spikes;
although the mutant replicated slower (small plaque mutant), it was
nevertheless infectious (Makino et al. 1983). Interestingly, type I IFN
is induced in N20.1 cells by MHV infection and pretreatment of N20.1
cells with IFNs inhibitedMHV infectivity (Li et al., 2010). Coincidently,
there is apparent deﬁciency of a higher molecular weight (possibly
glycosylated) S protein from IFN-producing, persistent N20.1 cells as
compared to that from IFN-nonproducing 17Cl-1 cells (Fig. 6C). Thus,
we speculate that, like VSV G protein, IFNs and possibly other cellular
factors that are induced by MHV infection in N20.1 cells subsequently
inhibit virus infectivity by blocking the incorporation of S protein into
virions during assembly. Such a possibility is currently under intense
investigation.
Materials and methods
Cells and virus
The N20.1 cell is a cell line clone derived from mouse primary
cultures of oligodendrocyte conditionally immortalized by transfor-
mation with a temperature-sensitive mutant of the simian virus 40
large-T antigen (Verity et al., 1993). It was kindly provided by Dr.
Anthony Compadre (University of California Los Angeles School of
Medicine). The N20.1 cell represents a mature oligodendrocyte
because it expresses the myelin basic protein (MBP) and myelin
proteolipid protein (PLP), but one that is at a very early stage of
maturity based on the expression of the MBP and PLP alternatively
spliced mRNA population (Verity et al., 1993). In addition, the N20.1
cell can be recognized by the A2B5 antibody, which recognizes a
surface galactolipid expressed by oligodendrocyte progenitor cells;
the A007 antibody, which is speciﬁc for sulfatide and found on cells
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oligodendrocytes, and the anti-GC antibody, which recognizes the
protein expressed speciﬁcally by mature oligodendrocytes (Verity
et al., 1993). The N20.1 cells were cultured in Dulbecco's modiﬁed
Eagle's medium (DMEM)/F12 with 10% fetal bovine serum (FBS) and
G418 (100 μg/ml) at the permissive temperature of 34 °C. Cells were
grown either in T25 ﬂasks or Petri dishes. The mouse oligodendroglial
precursor cell line Oligo-neu was kindly provided by Dr. Patricia
Wight (UAMS)with permission fromDr. Jacalyn Trotter (University of
Heidelberg, Germany). Mouse ﬁbroblast 17Cl-1 cells (kindly provided
by Dr. Susan Baker, Loyola University of ChicagoMedical Center) were
cultured in DMEM. Mouse astrocytoma DBT cells were cultured in
Eagle minimal essential medium (EMEM) and were used for virus
propagation and plaque assay as described previously (Liu et al.,
2003). The recombinant mouse hepatitis virus (MHV)-A59/GFP
expresses the green ﬂuorescence protein (GFP) that replaced the
viral nonstructural protein 4 (NS4) (kindly provided by Dr. Susan
Weiss, University of Pennsylvania School of Medicine). The virus was
propagated in DBT cells or 17Cl-1 cells.
Fluorescence-assisted cell sorting (FACS)
Following infection of N20.1 cells with MHV-A59/GFP at a
multiplicity of infection (m.o.i.) of 10, cells were observed for GFP
expression, which began at around 12 h p.i. and increased with time.
When strong GFP expression was observed (at≈48 h p.i.), cells were
trypsinized and prepared for FACS with the FACS ARIA (BD
Bioscience) in the departmental ﬂow cytometry core facility. Cells
were sorted into ﬂuorescence-positive and -negative groups, which
were then re-seeded separately for further study.
RNA isolation and conventional or real-time quantitative reverse
transcription-polymerase chain reaction (qRT-PCR)
For detection of viral RNAs in infected cells, intracellular total RNAs
were isolated from N20.1 cells using the Qiagen RNeasy plus Mini kit
(Cat.#74134) according to themanufacturer's protocol and treatedwith
RNase-freeDNase I (Qiagen). The concentration of the RNA sampleswas
determined with a spectrophotometer (Model U2001, Hitachi). For
detection of viral genome andmRNAs, conventional RT-PCRwas carried
out as described previously (Liu and Zhang, 2005). The following primer
pairs were used for detecting viral genomic RNA: The forward primer 5′
1a (5′-TGTGCCGAGTGA TGAGACGCA-3′) and reverse primer 3′1a (5′-
GCC ACA TAA CCA CCT TGT GGA AGG A-3′) for detecting gene 1a at nt
positions 3503–3742 (239 nt in length); 5′1b (5′-TGT GTA GGC ACA
GGC TCC CAG T-3′) and 3′1b (5′-CGT GTT CAG CCA CAA CAC CGC-3′) for
gene 1b at nt positions 1368–13891 (323 nt in length); 5′S1 (5′-GCT
TGTGAATTC AAACGG TGC TAA TGT-3′) and 3′S1 (5′-TGCAGT TGCACC
TGA TGG CGT-3′) for S1 gene at nt positions 23997–24291 (294 nt
in length); 5′S2 (5′-GCT GGG TGC TAT CCA GGA TGG GT-3′) and 3′S2
(5′-CGC GTG GTT TGG CTC TTA ACG C-3′) for S2 at nt positions 26868–
27194 (326 nt in length); 5′N(5′-ATGGAATCC TCAAGAAGA-3′) and 3′
N (5′-CCT GAG GCA ATA CCG TGC-3′) for N gene (500 nt in length). The
primer pairs: 5′Leader (5′-TTATAAGAG GATTGGCGTCCG-3′) and 3′S1,
and5′Leader and3′Nwereused to amplify the S (400 nt) andN (576 nt)
subgenomicmRNAs, respectively. In addition, the primer pair NF43 (5′-
TCC TCT GTA AAC CGC GCT GGT AAT-3′) and NR370 (5′-GCA GTA ATT
GCT TCT GCT GCC CAT-3′) was used for amplifying virion genomic RNA
corresponding to the sequence (328 nt) within the N gene shown in
Fig. 6. Primer pair 5′IG4 (5′-TTG ACT ATC ACA GCC TCT CC-3′, which is
located upstream of gene 4 and starts at nt 27901) and 3′-G5a (5′-GGC
ATG TGA GTG ATG CAT GG-3′, which is located within gene 5a at nt
28420) was used for amplifying gene 4 (GFP) from viral genomic RNA
and primer pair 5′Leader and 3′G5a for subgenomic mRNA4 (GFP). The
following primer pairs were used for amplifying the 3′-end of S gene,
and the full-length ofM and E genes, respectively: 5′Sc (5′-CTCGGC TTGAGG CTG TAG AAG C-3′, nt 27023) and 3′Sc (5′-ACA TGA GCC ACA ACC
TGTGCAGC-3′, nt 27813); 5′M(5′-TGAGACTGCCCCTATTAGAGGTGG
A-3′, nt 28923) and 3′M (5′-GAG GAG CTT CTG CCA CCG GC-3′, nt
29715); 5′E (5′-CGGCAGAAC TGTCCAACAGGCC-3′, nt 28620) and 3′E
(5′-TTGAACTGCCTCGTGGGCCG-3′, nt 29030). The PCRproductswere
analyzed by agarose gel electrophoresis.
For qRT-PCR, 1 ng of the total RNA sample was used in RT reaction
(25 μl) using the iScript cDNA synthesis kit (Bio-Rad Laboratories)
according to the manufacturer's instruction. The reaction was carried
out in an Applied Biosystems 9800 ThermoCycler in a 96-well plate for
5 min at 25 °C, 30 min at 42 °C, and 5 min at 85 °C and was then held
at 4 °C. Real-time qPCR was carried out in 50 μl reaction mixture
containing 1 μl RT product, 1× iQ SYBR Green Supermix PCR master
mix and 100 nM primers using an iCycler IQ Multicolor Real-time PCR
Detection system (Bio-Rad). The primer pair 5′qPCR (5′-TGC TTG GCT
TTC ACA CTT TGT CCC-3′) and 3′qPCR (5′-ACC CAC TGG ATA CCA GGC
TGA CAA-3′) ampliﬁes a 172-nt fragment of the viral genomic RNA
between nt 11402 and 11574. The PCR was performed in a 96-well
optical plate at 95 °C for 10 min, followed by 40 cycles of 95 °C for 15 s
and 57° for 1 min. Results were analyzed using the iCycler IQ
multicolor real-time PCR detection system (Bio-Rad Laboratories).
Gene expression levels in various experimental groups were calcu-
lated after normalizing cycle thresholds against the housekeeping
gene β-actin (using primer pair 5′b-actin: 5′-ACA GCT TTA CCA CCA
CTG CTG AGA-3′ and 3′b-actin: 5′-AGG AAG ATG ATG CAG CAG TAG
CCA-3′) and are presented as fold increase above the background from
mock-infected cells. The threshold cycle (Ct) is deﬁned as the
fractional cycle number at which the ﬂuorescence passes the ﬁxed
threshold. Relative gene expression values were determined using the
2−ΔΔCT method of Livak and Schmittgen (2001).
Western blot analysis
ForWestern blot analysis, whole cell lysates were prepared using cell
lysis buffer (Cat.#9038, Cell Signaling Inc.) according to the manufac-
turer's protocol. The protein concentration was determined by using Bio-
Rad protein assay kit. Equal amounts of total proteins were resolved by
sodium deoxyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and transferred onto nitrocellulosemembrane (Bio-Rad) for 7 h at 40 V in
the transfer buffer.Membraneswere blocked for 1 h at room temperature
with 5% powdered skim milk in Tris-buffered saline (10 mM Tris–Cl [pH
7.5], 150 mM NaCl) with 0.05% Tween 20 (TBST). The membranes were
incubated with a primary antibody at 4 °C overnight, followed by
incubation with a secondary horseradish-peroxidase (HRP)-conjugated
antibody (Sigma) for 1 h at room temperature. Blotsweredevelopedwith
Pierce® ECL Western Blotting Substrate and detection system (Thermo-
Fisher Scientiﬁc) and exposed to X-ray ﬁlm (Fuji). After the membranes
were incubated in stripping buffer (10 mMß-mercaptoethanol, 2% (w/v)
SDS, and 62.5 mM Tris, pH 6.7) at 55 °C for 30 min, they were washed in
TBST, blocked, and incubated with anti-β-actin mAb (as an internal
control) at room temperature for 1 h. Detection ofβ-actinwas carried out
following incubation with the secondary anti-mouse IgG antibody
conjugated with HRP and ECL. The following antibodies were used in
this study: A goat antibody againstMHV-A59 spike protein (termedA04),
a goat antibody speciﬁc to MHV E protein, and a mouse monoclonal
antibody toMHV N protein, which were kindly provided by Drs. Kathryn
Holmes (University of Colorado School of Medicine at Denver, CO), Julian
Leibowitz (University of Texas A&M, Health Science Center at College
Station, TX) and John Fleming (University ofWisconsinMedical Center at
Madison, WI), respectively.
Virus puriﬁcation and buoyant density determination
Virus preparation was puriﬁed from the cultured medium through
a 30% (w/v) sucrose cushion by ultracentrifugation at 27,000 rpm at
4 °C for 4 h in the SW28 rotor (Beckman Coulter). Virus pellets were
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puriﬁed through 10–70% (w/v) sucrose gradient by ultracentrifuga-
tion at 35,000 rpm at 4 °C overnight in an SW40 rotor (Beckman
Coulter). The gradient was then fractionated into 12 fractions. The
density of each fractionwas determinedwith a refractometer and was
further conﬁrmed with the simple weight and volume determination,
i.e. the weight of 100 μl of each fraction. The density was then plotted
as gram per milliliter.
Negative contrast electron microscopy
Negative contrast electron microscopy was carried out as described
previously (Zhang et al., 1994). Brieﬂy, formvar-coated copper grids
were ﬂoated for 15 min on drops of the concentrated virus suspension,
dried by lightly touching with ﬁlter paper and washed 1–2 times in de-
ionizedwater. Subsequently the gridswere stained byﬂoating for 1 min
ondropsof 1%phosphotungstate acid inPBS, and examinedwith a ZEISS
EM10/CR electron microscope (EM) at 60–80 kV.
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